Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery
Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (...
Gespeichert in:
Veröffentlicht in: | The Annals of thoracic surgery 2012-06, Vol.93 (6), p.1930-1935 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1935 |
---|---|
container_issue | 6 |
container_start_page | 1930 |
container_title | The Annals of thoracic surgery |
container_volume | 93 |
creator | Biancari, Fausto, MD, PhD Vasques, Francesco, MS Mikkola, Reija, MS Martin, Marta, MS Lahtinen, Jarmo, MD, PhD Heikkinen, Jouni, MD, PhD |
description | Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG). Methods Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version. Results EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p < 0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II ( p < 0.0001). Conclusions The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival. |
doi_str_mv | 10.1016/j.athoracsur.2012.02.064 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1017614561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003497512004262</els_id><sourcerecordid>1017614561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-e1b84f5224cb5e5e9aef901830a01e5ecff39d13c6ead8256c11f1df9cdc586e3</originalsourceid><addsrcrecordid>eNqNkVGLEzEQx4MoXj39CpIXwZetSTZJd1-Eu1K9wsEd1vM1pNlJTd0mNdk96Ld3Snse-CQMDMP8_jPJfwihnE054_rTdmqHnylbV8Y8FYyLKcPQ8gWZcKVEpYVqX5IJY6yuZDtTF-RNKVssBbZfkwshFNdNLSfk_oftQ2eHkCJNni7GnFbzu28LulzSEOk9diAOhT7EDvImhbih85RTtPlAr_IAmK4Pe1sKXY15g-Vb8srbvsC7c74kD18W3-c31e3d1-X86rZySqihAr5upFdCSLdWoKC14FvGm5pZxrF23tdtx2unwXaNUNpx7nnnW9c51WioL8nH09x9Tr9HKIPZheKg722ENBaDPs00l0pzRJsT6nIqJYM3-xx2-AOEjpw2W_Pspzn6aRiGlih9f94yrnfQ_RU-GYjAhzNgi7O9zza6UJ451UpZqxly1ycO0JPHANkUh8466EIGN5guhf95zed_hrg-xIB7f8EByjaNOaLnhpuCArM63v94fi4Yk0KL-g__cK3P</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017614561</pqid></control><display><type>article</type><title>Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Biancari, Fausto, MD, PhD ; Vasques, Francesco, MS ; Mikkola, Reija, MS ; Martin, Marta, MS ; Lahtinen, Jarmo, MD, PhD ; Heikkinen, Jouni, MD, PhD</creator><creatorcontrib>Biancari, Fausto, MD, PhD ; Vasques, Francesco, MS ; Mikkola, Reija, MS ; Martin, Marta, MS ; Lahtinen, Jarmo, MD, PhD ; Heikkinen, Jouni, MD, PhD</creatorcontrib><description>Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG). Methods Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version. Results EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p < 0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II ( p < 0.0001). Conclusions The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival.</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/j.athoracsur.2012.02.064</identifier><identifier>PMID: 22516834</identifier><identifier>CODEN: ATHSAK</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Area Under Curve ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiothoracic Surgery ; Cause of Death ; Coronary Artery Bypass - statistics & numerical data ; Coronary Artery Bypass, Off-Pump - statistics & numerical data ; Coronary heart disease ; Female ; Finland ; Heart ; Heart Arrest, Induced ; Hospital Mortality ; Humans ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Postoperative Complications - mortality ; Prognosis ; Propensity Score ; Reproducibility of Results ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart</subject><ispartof>The Annals of thoracic surgery, 2012-06, Vol.93 (6), p.1930-1935</ispartof><rights>The Society of Thoracic Surgeons</rights><rights>2012 The Society of Thoracic Surgeons</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-e1b84f5224cb5e5e9aef901830a01e5ecff39d13c6ead8256c11f1df9cdc586e3</citedby><cites>FETCH-LOGICAL-c525t-e1b84f5224cb5e5e9aef901830a01e5ecff39d13c6ead8256c11f1df9cdc586e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25944357$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22516834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Biancari, Fausto, MD, PhD</creatorcontrib><creatorcontrib>Vasques, Francesco, MS</creatorcontrib><creatorcontrib>Mikkola, Reija, MS</creatorcontrib><creatorcontrib>Martin, Marta, MS</creatorcontrib><creatorcontrib>Lahtinen, Jarmo, MD, PhD</creatorcontrib><creatorcontrib>Heikkinen, Jouni, MD, PhD</creatorcontrib><title>Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG). Methods Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version. Results EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p < 0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II ( p < 0.0001). Conclusions The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival.</description><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiothoracic Surgery</subject><subject>Cause of Death</subject><subject>Coronary Artery Bypass - statistics & numerical data</subject><subject>Coronary Artery Bypass, Off-Pump - statistics & numerical data</subject><subject>Coronary heart disease</subject><subject>Female</subject><subject>Finland</subject><subject>Heart</subject><subject>Heart Arrest, Induced</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Postoperative Complications - mortality</subject><subject>Prognosis</subject><subject>Propensity Score</subject><subject>Reproducibility of Results</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkVGLEzEQx4MoXj39CpIXwZetSTZJd1-Eu1K9wsEd1vM1pNlJTd0mNdk96Ld3Snse-CQMDMP8_jPJfwihnE054_rTdmqHnylbV8Y8FYyLKcPQ8gWZcKVEpYVqX5IJY6yuZDtTF-RNKVssBbZfkwshFNdNLSfk_oftQ2eHkCJNni7GnFbzu28LulzSEOk9diAOhT7EDvImhbih85RTtPlAr_IAmK4Pe1sKXY15g-Vb8srbvsC7c74kD18W3-c31e3d1-X86rZySqihAr5upFdCSLdWoKC14FvGm5pZxrF23tdtx2unwXaNUNpx7nnnW9c51WioL8nH09x9Tr9HKIPZheKg722ENBaDPs00l0pzRJsT6nIqJYM3-xx2-AOEjpw2W_Pspzn6aRiGlih9f94yrnfQ_RU-GYjAhzNgi7O9zza6UJ451UpZqxly1ycO0JPHANkUh8466EIGN5guhf95zed_hrg-xIB7f8EByjaNOaLnhpuCArM63v94fi4Yk0KL-g__cK3P</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Biancari, Fausto, MD, PhD</creator><creator>Vasques, Francesco, MS</creator><creator>Mikkola, Reija, MS</creator><creator>Martin, Marta, MS</creator><creator>Lahtinen, Jarmo, MD, PhD</creator><creator>Heikkinen, Jouni, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery</title><author>Biancari, Fausto, MD, PhD ; Vasques, Francesco, MS ; Mikkola, Reija, MS ; Martin, Marta, MS ; Lahtinen, Jarmo, MD, PhD ; Heikkinen, Jouni, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-e1b84f5224cb5e5e9aef901830a01e5ecff39d13c6ead8256c11f1df9cdc586e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiothoracic Surgery</topic><topic>Cause of Death</topic><topic>Coronary Artery Bypass - statistics & numerical data</topic><topic>Coronary Artery Bypass, Off-Pump - statistics & numerical data</topic><topic>Coronary heart disease</topic><topic>Female</topic><topic>Finland</topic><topic>Heart</topic><topic>Heart Arrest, Induced</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Postoperative Complications - mortality</topic><topic>Prognosis</topic><topic>Propensity Score</topic><topic>Reproducibility of Results</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Biancari, Fausto, MD, PhD</creatorcontrib><creatorcontrib>Vasques, Francesco, MS</creatorcontrib><creatorcontrib>Mikkola, Reija, MS</creatorcontrib><creatorcontrib>Martin, Marta, MS</creatorcontrib><creatorcontrib>Lahtinen, Jarmo, MD, PhD</creatorcontrib><creatorcontrib>Heikkinen, Jouni, MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Biancari, Fausto, MD, PhD</au><au>Vasques, Francesco, MS</au><au>Mikkola, Reija, MS</au><au>Martin, Marta, MS</au><au>Lahtinen, Jarmo, MD, PhD</au><au>Heikkinen, Jouni, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>93</volume><issue>6</issue><spage>1930</spage><epage>1935</epage><pages>1930-1935</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><coden>ATHSAK</coden><abstract>Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG). Methods Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version. Results EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p < 0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II ( p < 0.0001). Conclusions The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22516834</pmid><doi>10.1016/j.athoracsur.2012.02.064</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4975 |
ispartof | The Annals of thoracic surgery, 2012-06, Vol.93 (6), p.1930-1935 |
issn | 0003-4975 1552-6259 |
language | eng |
recordid | cdi_proquest_miscellaneous_1017614561 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Area Under Curve Biological and medical sciences Cardiology. Vascular system Cardiothoracic Surgery Cause of Death Coronary Artery Bypass - statistics & numerical data Coronary Artery Bypass, Off-Pump - statistics & numerical data Coronary heart disease Female Finland Heart Heart Arrest, Induced Hospital Mortality Humans Kaplan-Meier Estimate Logistic Models Male Medical sciences Middle Aged Pneumology Postoperative Complications - mortality Prognosis Propensity Score Reproducibility of Results Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart |
title | Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A10%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20EuroSCORE%20II%20in%20Patients%20Undergoing%20Coronary%20Artery%20Bypass%20Surgery&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Biancari,%20Fausto,%20MD,%20PhD&rft.date=2012-06-01&rft.volume=93&rft.issue=6&rft.spage=1930&rft.epage=1935&rft.pages=1930-1935&rft.issn=0003-4975&rft.eissn=1552-6259&rft.coden=ATHSAK&rft_id=info:doi/10.1016/j.athoracsur.2012.02.064&rft_dat=%3Cproquest_cross%3E1017614561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017614561&rft_id=info:pmid/22516834&rft_els_id=S0003497512004262&rfr_iscdi=true |